Literature DB >> 9781658

Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases.

L Catasus1, P Machin, X Matias-Guiu, J Prat.   

Abstract

Instability at microsatellite repeat sequences (MI) has been observed in endometrial carcinomas (EC) arising sporadically or in association with the hereditary colon cancer syndrome. However, the clinical and pathological features of the EC with MI have not been characterized. DNA of 42 patients with EC was extracted from blood and from fresh-frozen and paraffin-embedded tumor tissue. Microsatellite loci on chromosomes 4, 5, 10, 12, 17, and 18 were amplified by polymerase chain reaction. MI was defined by a mobility shift in the tumor DNA as compared with normal DNA. Results were correlated with the clinical and pathological features of the tumors. MI at three or more loci was detected in 12 of 42 cases (28%). There were no significant differences between EC with and without MI with regard to age of presentation, stage, evidence of estrogenic stimulation, mucinous differentiation, estrogen receptor, c-erbB2, or p53 immunostaining. However, MI was more frequent in endometrioid (11/33, 33.3%) than in nonendometrioid (1/9, 11%) carcinomas. Only one papillary serous carcinomas showed MI. MI was found in one of two cases of endometrial hyperplasia adjacent to EC. It was concluded that MI is a common genetic abnormality of endometrial carcinoma and appears to be more frequent in endometrioid than in nonendometrioid tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781658     DOI: 10.1016/s0046-8177(98)90430-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

Review 1.  Application of molecular diagnostics for the detection of Lynch syndrome.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Expert Rev Mol Diagn       Date:  2010-07       Impact factor: 5.225

2.  Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.

Authors:  Ekene I Okoye; Amanda S Bruegl; Bryan Fellman; Rajyalakshmi Luthra; Russell R Broaddus
Journal:  Int J Gynecol Pathol       Date:  2016-01       Impact factor: 2.762

3.  hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.

Authors:  M Esteller; L Catasus; X Matias-Guiu; G L Mutter; J Prat; S B Baylin; J G Herman
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Biomarkers in endometrial cancer: Possible clinical applications (Review).

Authors:  Kouji Banno; Iori Kisu; Megumi Yanokura; Kosuke Tsuji; Kenta Masuda; Arisa Ueki; Yusuke Kobayashi; Wataru Yamagami; Hiroyuki Nomura; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Lett       Date:  2012-03-26       Impact factor: 2.967

5.  Insights into endometrial serous carcinogenesis and progression.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2009-01-10

6.  DcR1 expression in endometrial carcinomas.

Authors:  Jordi Tarragona; Nuria Llecha; Maria Santacana; Susana Lopez; Sonia Gatius; David Llobet; Xavier Dolcet; Victor Palomar-Asenjo; Francisco Javier Gonzalez-Tallada; Xavier Matias-Guiu
Journal:  Virchows Arch       Date:  2009-11-20       Impact factor: 4.064

Review 7.  Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.

Authors:  Sigurd F Lax
Journal:  Virchows Arch       Date:  2004-01-28       Impact factor: 4.064

8.  Mismatch repair and treatment resistance in ovarian cancer.

Authors:  Jozien Helleman; Iris L van Staveren; Winand N M Dinjens; Patricia F van Kuijk; Kirsten Ritstier; Patricia C Ewing; Maria E L van der Burg; Gerrit Stoter; Els M J J Berns
Journal:  BMC Cancer       Date:  2006-07-31       Impact factor: 4.430

9.  Microsatellite instability at a tetranucleotide repeat in type I endometrial carcinoma.

Authors:  Yoo Duk Choi; Jin Choi; Jo Heon Kim; Ji Shin Lee; Jae Hyuk Lee; Chan Choi; Ho Sun Choi; Min Cheol Lee; Chang Soo Park; Sang Woo Juhng; Jong Hee Nam
Journal:  J Exp Clin Cancer Res       Date:  2008-12-31

10.  Current status of molecular-targeted drugs for endometrial cancer (Review).

Authors:  Yuya Nogami; Kouji Banno; Iori Kisu; Megumi Yanokura; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Wataru Yamagami; Hiroyuki Nomura; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2013-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.